Search Results
Search this site
66 results found
- Microbiome Skin Sampling Kit | Sequential
Video on how to take a microbiome sample with Sequential's microbiome testing kit.
- Press | Sequential
Sequential in the news. Press coverage, announcements and the milestones we're reaching across our clinical research and multi-omics platform. Sequential in the Press Men’s grooming shifts toward science-driven solutions 24-Feb-2026 Read Now Sequential: Testing shows skin microbiome plays a role in hyperpigmentation 7-Oct-2025 Read Now The bidirectional skin-gut microbiome: a game-changer for cosmetic formulators 29-Jul-2025 Read Now Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project 13-Feb-2025 Read Now Sequential Launches Industry-First Microbiome Target Panels for Skin Conditions 16-Oct-2024 Read Now From the experts: Top 3 trends in skin microbiome research 20-Jun-2024 Read Now Is Home-Based Skin Microbiome Testing Transforming Beauty and Health Care Industry? 7-Dec-2023 Read Now “Hormone-led changes cause differences to the vaginal ecology that can have an effect on women’s health later in life.” CEO of Sequential 13-Sep-2023 Read Now Sequential and Johnson & Johnson enter partnership to develop new genomic-based skin test 16-Mar-2023 Read Now Sequential Announces New Collaboration Agreement to Quantify Skin Health 15-Mar-2023 Read Now ‘Natural evolution’: Gallinée unveils at-home skin microbiome test kits with Sequential Skin 09-Mar-2023 Read Now Here They Are: Congratulations to the Winners of the 2022 C&T Allēs 29-Sep-2022 Read Now Sequential Skin: Why We Invested 11-Apr-2022 Read Now Sequential Skin Debuts Sequential Bio Testing Solution 09-Mar-2022 Read Now Biotech Start-Up Sequential Skin Raises Funds 10-Dec-2021 Read Now Biotech startup Sequential Skin raises €1.4m – ‘We want to accelerate the future of skin health,’ says CEO 11-Oct-2021 Read Now PODCAST – Holistic view on skin: Sequential Skin on why microbiome testing is crucial to personalised beauty 21-Aug-2020 Read Now Beauté personnalisée: Sequential Skin la Beauty Tech made in Singapore 07-Jul-2020 Read Now GWS 2019 DAY 2 Beauty, Science & Technology: Skin in the Game 25-Nov-2019 Read Now Science-led minimalism shapes future sustainable skin care 13-Jan-2026 Read Now Beautiful Bacteria: Are We On The Cusp Of Microbiome Mainstreaming? 28-Sep-2025 Read Now Sequential Skin and AMILI Secure $1.8M UK-Singapore Grant to Advance Gut-Skin Microbiome Science 14-Feb-2025 Read Now 50694 Gut microbiome differences between patients with moderate to severe Chronic Hand Eczema and healthy subjects Sep-2024 Read Now Is Microbiome Certification even Necessary? 29-Jul-2024 Read Now ‘It’s a really delicate system’: Research on vaginal microbiome shows how little we know about femcare 22-Jan-2024 Read Now Gallinée lance le premier test de santé de la peau et du microbiome à réaliser chez soi 10-Oct-2023 Read Now Lysine-dendrimer: a gentle yet effective acne treatment that maintains skin microbiome, says study 18-Aug-2023 Read Now Acne and ageing: J&J exploring skin health markers via Sequential Skin research tie-up 15-Mar-2023 Read Now Sequential Skin x Johnson & Johnson Collab to Quantify Skin Health 14-Mar-2023 Read Now Understand before purchase: Microbiome testing can help consumers find the right products and eliminate waste 30-Jan-2023 Read Now Sequential Wins New Grant To Propel Skin Microbiome Research 30-Jun-2022 Read Now Sequential Skin launches test to assess ingredient effect on microbiome 22-Mar-2022 Read Now Microbiome start-up Sequential Bio debuts first in-vivo testing for personal care industry 04-Mar-2022 Read Now Sequential Skin Raises $1.6M in Oversubscribed Seed Round 12-Oct-2021 Read Now The skin microbiome brainstorm: Tech, claims and trend-driven NPD 16-Sep-2021 Read Now Skin Sensors Enable Personalized Skin Care 20-Aug-2020 Read Now Sequential Skin: beauty tech’s new approach to genetic analysis and microbiome skincare 09-Mar-2020 Read Now How genetic insights can personalise skin microbiome launches 29-Jul-2019 Read Now Deep dive into Radiance Evaluation 9-Oct-2025 Read Now Men’s care shifts toward function-first to address skin needs beyond the basics 16-Sep-2025 Read Now Sequential and AMILI secure $1.8M UK-Singapore R&D project to advance gut-skin microbiome science 13-Feb-2025 Read Now New clinical testing to “investigate microbial roots of various skin conditions” 17-Oct-2024 Read Now Losing its meaning? ‘Microbiome-friendly’ terms at risk of misleading consumers – Sequential CEO 29-Jul-2024 Read Now Navigating the realm of intimate care products 17-Jan-2024 Read Now Avec ce test microbiome maison, 10 secondes m'ont suffit pour découvrir les besoins de ma peau 04-Oct-2023 Read Now Lysine-Dendrimer, a New Non-Aggressive Solution to Rebalance the Microbiota of Acne-Prone Skin 3-Aug-2023 Read Now Sequential Announces New Collaboration Agreement to Measure Skin Health for Leading Developer of Personal Care Products 15-Mar-2023 Read Now Sequential Skin partners with Johnson & Johnson on microbiome tests 10-Mar-2023 Read Now Symbiome Partners with Skin Microbiome Testing experts at Sequential to Revolutionize Beauty Industry 26-Jan-2023 Read Now Sequential Skin Nabs $500K UK Grant to Study Skin Microbiome in Atopic Dermatitis 29-Jun-2022 Read Now Demands rising for clinical data on the skin microbiome: Experts 22-Mar-2022 Read Now ‘Maintaining the microbiome’: Biotech startup Sequential Skin debuts in vivo B2B testing service 03-Mar-2022 Read Now Start-up Sequential Skin bags $1.65m of fresh funding 12-Oct-2021 Read Now Singapore Beauty Startup Sequential Skin Uses Science to Help Identify the Best Skincare For You 07-Jan-2021 Read Now Overlooked opportunities? Skin microbiome may play a more important role in personalisation than DNA 13-Aug-2020 Read Now Sequential tool kit prioritises personalisation 15-Jan-2020 Read Now
- Find Us | Sequential
Throughout the year, Sequential has the pleasure of going to various conferences and trade shows where we talk all things microbiome testing and clinical studies. Don't miss us when we're in your city next! Connect With Us At Conferences At Sequential, we believe in the power of personal connections and the exchange of ideas to foster innovation and growth. As we actively participate in various conferences and industry events, we invite you to be a part of these enriching experiences. Explore the opportunities to engage with our team, discover the latest industry trends, and strengthen the bonds that drive mutual success. Join us at conferences to connect, learn, and pave the way for future collaborations. Where we will be in 2026 3-5 November BITEC, Bangkok, Thailand 10-11 November Coventry, United Kingdom In-Cosmetics Asia We are incredibly excited to be attending this year's Asia edition in partnership with Skinobs. SCS Formulate Visit us at Booth (903) at this year’s SCS Formulate to learn more about our work and speak with the team. Supporting Global Studies Our Labs Sequential has clinical testing labs in New York City, Cambridge, and Singapore. Being close to our customers has allowed us to reduce turnaround time while retaining intellectual property in-house. Cambridge Lab Moneta Building Babraham Research Campus, Cambridge CB22 3AT New York Lab Sequential (SOSV) 7 Penn Plaza, 9th Fl, New York NY 10001 Singapore Lab Astar Central 79 Ayer Rajah Crescent, Singapore 139955
- Active Ingredient Testing for Manufacturers | Sequential
Validate the efficacy, dose-response, and biological impact of cosmetic and pharmaceutical actives in real formulations using human and microbiome biomarkers. SKIN SCALP ORAL INTIMATE SUPPLEMETS Prove the efficacy of your active ingredient on real skin. We help ingredient manufacturers generate robust, clinically relevant evidence by testing actives within controlled formulations, delivering clear insight into biological impact and optimal performance. Prove your product’s impact The challenge Validating ingredient performance Demonstrating the efficacy of a novel ingredient is rarely straightforward. Raw actives cannot be meaningfully tested in isolation, yet many studies fail to reflect real-world use within formulations, limiting the relevance of results. Without a structured, comparative study design, it becomes difficult to: Isolate the true impact of an ingredient Ingredient testing Designed for real-world application Sequential evaluates active ingredients within controlled base formulations, ensuring results reflect how ingredients perform on human skin. We design studies to isolate and quantify ingredient impact through two core approaches: Active vs control formulations. Assess the biological effect of an ingredient against a matched base formulation. Dose-response evaluation Compare different concentrations of the same active to determine optimal performance and efficacy thresholds. By integrating biomarker profiling, microbiome analysis, and clinically relevant endpoints, we generate clear, reproducible insight into ingredient activity. ingredient impact Understand the true biological effect of your active within a controlled formulation environment. Dose-response clarity Determine optimal concentration ranges through structured comparative study design. Claim-ready evidence Generate robust, biomarker-driven data to support technical documentation and commercial claims.
- Privacy Policy | Sequential
At Sequential we take your privacy seriously. For a full breakdown, please read through our policy on how we use your information for microbiome product testing. Privacy Policy Last updated: Jul 28, 2026 Sequential Skin Ltd is committed to using personal information lawfully, fairly and transparently. This Privacy Policy explains how we use personal information in connection with sequential.bio (the Site), general business communications, marketing, supplier and customer relationships, and recruitment. Separate privacy information may apply to a research study, clinical or consumer testing programme, sample analysis, app, portal, customer project or employee relationship. If a specific notice is provided for one of those activities, that notice applies to that activity and takes priority if there is any inconsistency. 1. Who we are and how to contact us Sequential Skin Ltd is a company registered in England and Wales under company number 12547483. Our registered office and postal address is Moneta (B280), Babraham Research Campus, Babraham, Cambridgeshire, CB22 3AT, United Kingdom. For the processing described in this policy, Sequential Skin Ltd is generally the controller. In some customer-sponsored studies or projects, we may act only as a processor on another organisation's instructions; in that case, the relevant controller's privacy notice explains how your information is used. Privacy enquiries and rights requests: team@sequential.bio 2. Scope of this policy This policy applies to visitors to the Site, people who contact us, newsletter subscribers, prospective and current business contacts, customer and supplier representatives, job applicants, and other individuals whose information we process for our own business purposes. The Site is not directed at children. A study involving a child or young person will use a specific recruitment, consent and privacy process appropriate to that study. 3. Personal information we collect Identity and contact information. Name, title, employer, role, postal address, email address, telephone number and account identifiers. Business and relationship information. Organisation, sector, professional interests, correspondence, meeting notes, enquiries, proposals, contract details and relationship history. Marketing information. Subscription choices, preferred topics and channels, consent records, objections, suppression records and engagement with communications. Technical and usage information. IP address, browser and device information, time zone, approximate location derived from IP, security logs, identifiers and information about how the Site and emails are used. Account and security information. Login or authentication records, permissions, activity logs and information used to prevent fraud, abuse or unauthorised access. Recruitment information. CV, qualifications, employment history, work eligibility, application responses, interview notes, references and information reasonably required to assess an application. Other information you provide. Information included in forms, messages, documents, feedback or support requests. 4. Special category and study information Please do not send health, genetic, biometric or other special category information through a general website or contact form unless we specifically ask for it and explain why it is needed. If you apply for or take part in a research study, clinical study, consumer testing programme or sample-based service, Sequential or the relevant sponsor may process health, genetic, biometric, microbiome or other sensitive information. A study- or service-specific notice will identify the controller and explain the purpose, lawful basis, applicable special-category condition, safeguards, retention and sharing. Study participation and consent to take part in research are separate from consent used as a data-protection lawful basis. 5. How we obtain information We obtain information directly from you when you use the Site, contact us, subscribe, meet with us, enter a business relationship or apply for a role. We also obtain information automatically from devices and services, subject to cookie choices. We may obtain business contact information from your employer or colleagues, event organisers, professional networks, referral partners, publicly available professional sources, service providers, recruitment agencies or customers and partners. When information is obtained from another source, we provide privacy information as required by law unless an exception applies. 6. Why we use information and our lawful bases Operate and secure the Site. To deliver pages and requested features, maintain availability, prevent misuse, troubleshoot and protect systems. We rely on legitimate interests in operating a secure and effective website, legal obligations where applicable, and consent for optional technologies where required. Respond to enquiries and develop relationships. To communicate, arrange meetings, understand requirements, prepare proposals and manage prospective or current customer, supplier and partner relationships. We rely on steps requested before a contract, performance of a contract, and legitimate interests in running and developing our business. Provide and administer contracted services. To onboard organisations, administer accounts, communicate about delivery, invoice, maintain records and enforce agreements. We rely on contract where you are a contracting individual, legitimate interests where the contract is with your organisation, and legal obligations. Marketing and events. To send newsletters, invitations and relevant business communications, measure engagement and manage preferences. We rely on consent where required by electronic-marketing law and otherwise on legitimate interests, subject to your right to object. Every direct marketing message will offer an appropriate way to opt out. Improve services and understand use. To analyse feedback and, where permitted, Site usage, identify trends and improve content, services and user experience. We rely on legitimate interests and on consent for cookies or similar technologies where required. Recruit people. To manage applications, assess suitability, communicate with candidates, check eligibility, take steps before an employment contract and protect legal rights. We rely on steps before contract, legal obligations and legitimate interests in recruitment and defending claims. Any special category information is used only under an applicable legal condition. Meet legal and compliance obligations. To keep records, respond to rights requests and complaints, comply with tax, accounting, corporate, regulatory or court requirements, and establish, exercise or defend legal claims. We rely on legal obligations and legitimate interests. Corporate transactions. To evaluate or complete an investment, financing, restructuring, sale, merger or transfer, with appropriate confidentiality and data-protection safeguards. We rely on legitimate interests in managing our business and assets and legal obligations where applicable. Where we rely on legitimate interests, we consider the necessity of the processing and balance our interests against the impact on your rights and freedoms. You may ask for more information about that assessment. 7. Marketing choices You can unsubscribe from marketing emails using the link in the message or by contacting us. We may continue to send service, security, legal or relationship communications that are not direct marketing. We keep a minimal suppression record after an opt-out so that we can respect your choice. Electronic-marketing rules vary by recipient type. We obtain consent where required and do not use pre-ticked boxes or treat silence as consent. Business contacts can object to direct marketing at any time. 8. Cookies and similar technologies Our Cookie Policy explains the technologies used on the Site, when consent is required, and how to change your choices. Optional technologies are controlled through Cookie Settings. Cookie Policy: sequential.bio/cookiepolicy 9. When we share information We share personal information only where necessary and subject to appropriate safeguards. Recipients may include: hosting, cloud, communications, security, analytics, customer-relationship, marketing and other technology providers; professional advisers, auditors, insurers, banks and payment providers; customers, suppliers, research partners, laboratories, clinical research organisations or study sponsors where relevant and explained in the applicable relationship or specific notice; recruitment agencies, screening providers and referees in connection with applications; regulators, courts, law enforcement and public authorities where disclosure is required or permitted by law; and prospective buyers, investors, lenders or counterparties and their advisers in connection with a corporate transaction, subject to confidentiality and appropriate controls. Service providers acting as processors may use information only on our documented instructions, must protect it and must not use it for their own unrelated purposes. Where another recipient acts as an independent controller, its own privacy notice also applies. 10. International transfers Some providers or recipients may be located outside the United Kingdom, or may allow access from another country. When we make a restricted transfer, we use a lawful transfer mechanism, such as UK adequacy regulations or appropriate safeguards including the UK International Data Transfer Agreement or the UK Addendum to approved standard contractual clauses. Where required, we complete a data protection test or transfer risk assessment and apply supplementary safeguards. We use a legal exception only where the law permits and the conditions are met. You may contact us for more information about the transfer mechanism relevant to your information, subject to lawful confidentiality restrictions. 11. How long we keep information We keep personal information only for as long as reasonably necessary for the purpose for which it was collected, including legal, accounting, reporting, security and dispute-resolution requirements. We use a documented retention approach that considers the amount, nature and sensitivity of the information, risk of harm, purpose, whether the purpose can be achieved another way, and applicable limitation or regulatory periods. Enquiries and business contacts. For the active relationship and a reasonable follow-up period, then deletion or minimisation unless records are needed for a contract, legal obligation or claim. Contracts and transaction records. For the contract and the relevant legal, tax, accounting and limitation periods after it ends. Marketing. Until you opt out or the information is no longer needed under our review rules; a minimal suppression record may be kept longer to respect the opt-out. Recruitment. For the recruitment exercise and a reasonable period to manage queries or claims, or longer with permission where we wish to consider you for future roles. Security and technical logs. For a proportionate period based on security, troubleshooting and legal needs. Studies and sensitive processing. As stated in the applicable study, service or participant notice and relevant protocol or contract. 12. Security We use appropriate technical and organisational measures designed to protect personal information against accidental or unlawful destruction, loss, alteration, disclosure or access. Measures are selected according to risk and may include access controls, confidentiality obligations, encryption in transit or at rest where appropriate, backups, monitoring, supplier due diligence and incident procedures. No internet transmission or storage system can be guaranteed completely secure. 13. Your data protection rights Depending on the circumstances, you may have the right to: be informed about how your personal information is used; request access to your personal information; request correction of inaccurate or incomplete information; request erasure of information where there is no lawful reason to continue using it; request restriction of processing in specified circumstances; object to processing based on legitimate interests and object at any time to direct marketing; receive or transfer certain information in a structured, commonly used and machine-readable format; withdraw consent at any time where processing is based on consent, without affecting earlier lawful processing; and ask for safeguards where a significant decision is made solely by automated processing, where applicable. These rights are not absolute and exemptions may apply. We may ask for information reasonably needed to confirm identity or clarify a request. We normally respond without undue delay and within the period required by law. A fee is not normally charged, but the law permits a reasonable fee or refusal in limited cases, such as manifestly unfounded or excessive requests. 14. Automated decision-making We do not currently use personal information collected through the Site to make decisions based solely on automated processing that produce legal or similarly significant effects. If that changes, we will provide specific information about the logic, significance, consequences and safeguards, including how to obtain human intervention and contest a decision. 15. Data protection complaints If you believe we have used your personal information unlawfully, contact us at team@sequential.bio or by post at Moneta (B280), Babraham Research Campus, Babraham, Cambridgeshire, CB22 3AT, United Kingdom and mark the correspondence "Data protection complaint". We will help you make the complaint, acknowledge it within 30 days, investigate it, keep you appropriately informed and tell you the outcome without undue delay. You may also complain to the Information Commissioner's Office, the United Kingdom supervisory authority. We would appreciate the opportunity to address your concern first, but this does not affect your right to contact the ICO. ICO complaints information: ico.org.uk/make-a-complaint 16. Third-party links The Site may contain links, plug-ins or embedded content provided by third parties. Those organisations may collect information under their own privacy notices. We do not control their independent processing and encourage you to review their notices. 17. Changes to this policy We review this policy and may update it when our activities or legal requirements change. The date at the top shows the latest revision. If a change materially affects how we use information already collected, we will take reasonable steps to bring it to the attention of affected people and obtain consent where required. Contact us Questions about this Privacy Policy, your rights or a data protection complaint may be sent to: Sequential Skin Ltd (company number 12547483) Moneta (B280), Babraham Research Campus, Babraham, Cambridgeshire, CB22 3AT, United Kingdom Email: team@sequential.bio
- Human Biomarker Analysis | Sequential
Measure the body's biological response to your product or treatment. Human biomarker panels show changes in the host, not only in the microbes on it. Human Biomarker Analyses Our mission is clear: to understand the impact of the microbiome on humans and how humans impact the microbiome, in order to fully characterise human health. Our Multi-Omic Studies bring us back to the core of our mission by offering an unparalleled approach to skin health research. Start your study today Our Layers of Analysis Genetic Profiling Identify key genetic markers linked to health, aging, and disease susceptibility. SNP Detection. Predict responsiveness to product. Metabolomics Map metabolic pathways to assess skin and body health, aging, and personalized wellness. Metabolic shift pre- and post-product application. Human Gene Expression Uncover how genes are activated in response to lifestyle, environment, and treatments. The effect of product on skin-related microbial gene expression. Protein Profiling Analyse protein biomarkers to track biological changes and optimise product efficacy. Understand how a product impacts the skin's fungal community. Lipid Profiling Investigate lipid composition for insights into skin barrier function and metabolic health. Assess how a product restores lipid homeostasis. Our Test Areas Skin Test skin formulations, actives and finished products from cleansers, serums and moisturisers to SPFs and treatments. Sequential Skin Patch™ Find Out More Why Sequential? Claim Ready Science Molecular evidence for claims broken down into market positioning insights. Real World Testing Studies done on real people from our global, expansive database. End-to-End Platform We’ll handle everything for you from study design and recruitment to market advice. Flexible & Scalable In-lab or remote studies made possible via our proprietary Sequential Skin Patch™.
- Next Generation of Ingredients & Validation| Sequential
The Future of Next-Generation Ingredients & Validation. A full day for senior R&D, innovation and scientific leaders across beauty, personal care and biotechnology, exploring multiomics, the skin microbiome, bioengineered actives and the evidence the market now demands. About the event Where ingredient innovation meets the evidence behind it Sequential is bringing together senior R&D, innovation and scientific leaders from across the beauty, personal care and biotechnology industries for an exclusive full-day event on the future of next-generation ingredient innovation and validation. Expect sharp, practical talks, a moderated roundtable and time to connect with peers. FORMAT: Talks · Panel · Roundtable AUDIENCE: Senior R&D & Innovation Leaders VENUE: Attenborough Room, The Mills Fabrica, London Voices From Across the Industry Lieve Declercq Proya Cosmetics Regenerative biotechnology, a biomimetic Collagen XVII platform, and the future of global R&D collaboration between China and Europe. Dr. Albert Dashi Sequential Chief Science Officer & Co-founder. Behind the science: how Sequential validates next-generation ingredient claims. John Milligan The Honey Pot Company Destigmatizing intimate health and formulating for the fast-growing women’s health category. Christina Patane Medik8 Longevity, the skin microbiome, and Medik8’s five-year innovation roadmap. Martin Pagac DSM-Firmenich 3D facial microbiome mapping and the emerging role of human milk oligosaccharides (HMOs) in skin health. Veronika Oudova S-Biomedic Building the live skin probiotic category, the founder’s journey from idea to market. Dr. Amir Jassim AI Specialist Formerly University of Cambridge & Cancer Research UK. A fast-paced look at where AI is accelerating discovery and validation. On the day Thursday 3 December, 9:00am – 4:30pm Attenborough Room, The Mills Fabrica, London. Timings may shift slightly as the programme is finalised. 9:00am Registration & arrival coffee 10:00am Welcome & introduction to Sequential 10:15am Keynote: Dr. Lieve Declercq — Proya Chief Scientific Advisor & VP of European Innovation From Frontier Skin Science to Breakthrough Beauty Innovation 10:45am Cristina Patane — Medik8 Senior Formulation Scientist (Futures) Blue-Sky Beauty 11:10am Martin Pagac — dsm-firmenich Senior Scientist, PhD, Skin Biology Mapping and Modulating the Skin Microbiome 11:35am Coffee break 12:05pm Dr. Albert Dashi — Sequential Chief Science Officer & Co-founder Building the Clinical Testing Engine 12:30pm John Milligan — The Honey Pot Company VP R&D Women’s Health with Next-Generation Ingredients & Validation 12:55pm Veronika Oudova — S-Biomedic (Beiersdorf) Co-founder From Concept to Shelf 1:20pm Lunch break 1:50pm Science & Marketing Story Workshop 2:50pm Dr. Amir Jassim — AI Specialist Formerly University of Cambridge & Cancer Research UK AI in Ingredient Discovery 3:15pm Francisco González — Cobiosa R&D Director Skin Longevity: Bridging Science, Evidence and Innovation 3:40pm Dr. Ramdane Haddouche — Croda Research and Technology Specialist Topic to be announced 4:05 pm Roundtable discussion with the day’s speakers 4:25pm Networking break & cocktail hour at the pub (until 7pm)
- How do I rebuild my skin microbiome?
How do I Rebuild my Skin Microbiome? How do I Rebuild my Skin Microbiome? Our skin, as we know to be the body's largest organ, hosts a plethora of microorganisms. An elaborate ecosystem of bacteria, fungi, and viruses that live on the skin and maintain its optimal health, making up the skin microbiome (Smythe & Wilkinson, 2023). These microorganisms serve as a protective barrier against harmful pathogens, aid in immune system regulation, and play a vital role in various skin functions. However, factors such as harsh skincare products, poor diet, and environmental stressors can disrupt the balance, leading to acne, eczema, and other skin disorders (Wallen-Russell, 2019). Restoring the skin microbiome involves a complex and multifaceted approach that includes lifestyle changes, targeted skincare practices, and sometimes dietary adjustments. Understanding the Skin Microbiome The microbiome varies depending on the region of the skin, with different areas hosting distinct microbial communities. Fournière et al. (2020) examine how Staphylococcus epidermidis and Cutibacterium acnes, key skin microbiota components, vary across different skin environments. For instance, Staphylococcus species are mainly in moist areas like axillary and popliteal creases, while Cutibacterium species are found in sebaceous areas such as the face and back. An ideal and healthy skin microbiome is diverse, and resilient, capable of adapting to changes and defending against adversaries. Steps to Restore the Skin Microbiome 1. Use Less & Gentle Skincare Products: Using lesser products would simplify one’s skincare routine, making it easier to stay consistent and therefore allow the skin to adjust and benefit from the active ingredients. Hwang et al. (2021) further suggests that in order to restore the skin microbiome, one should actively choose products with essential ingredients which are natural, soothing and non-disruptive to the skin's natural barrier. 2. Incorporate Probiotics, Prebiotics and Postbiotics: Just as the gut microbiome benefits from probiotics, so does the skin. Probiotic skincare adds beneficial bacteria to restore skin balance, while prebiotics nourish existing good bacteria to boost their growth. Common probiotics include Lactobacillus and Bifidobacteria, found in drinks, powders, tablets, and fermented dairy products (Gowda, et al. 2024). 3. Protect Your Skin from Environmental Stressors: Limit exposure to environmental pollutants and the sun, which can damage the skin barrier and disrupt the microbiome (Wang et al., 2021). Using protective measures like sunscreen, wearing protective clothing, and cleansing your skin regularly can help maintain the integrity of the skin barrier and support a balanced microbiome. 4. Moisturise Regularly: Keeping the skin well-hydrated is crucial for maintaining a healthy microbiome. Dry skin can compromise the skin barrier, making it easier for harmful bacteria to invade. Use a moisturiser that contains ingredients like ceramides, which help to strengthen the skin barrier, and hyaluronic acid to retain moisture. (Spada & Greive, 2018) 5. Pay Attention to Diet: A diet rich in fruits, vegetables, and whole grains supports skin microbiome health with essential vitamins, minerals, and antioxidants. Omega-3 fatty acids, found in fish and flaxseeds, are particularly beneficial as they have anti-inflammatory properties that can help maintain a balanced skin microbiome. (Costantini, Molinari & Merendino, 2017) Conclusion Restoring the skin microbiome is an ongoing process that demands consistent effort and dedication. By understanding the skin microbiome and incorporating strategies to support its health, you can significantly enhance your skin's ability to protect against environmental stressors and lower the risk of skin disorders. References Smythe, P., & Wilkinson, H. N. (2023). The skin microbiome: Current landscape and future opportunities. International Journal of Molecular Sciences, 24(4), 3950. https://doi.org/10.3390/ijms24043950 Wallen-Russell, C. (2019). The impact of skin care products on skin chemistry and microbiome dynamics. BMC Biology, 17(1), 47. https://doi.org/10.1186/s12915-019-0660-6 Fournière, M., Latire, T., Souak, D., Feuilloley, M. G. J., & Bedoux, G. (2020). Staphylococcus epidermidis and Cutibacterium acnes: Two major sentinels of skin microbiota and the influence of cosmetics. Microorganisms, 8(11), 1752. https://doi.org/10.3390/microorganisms8111752 Hwang, B. K., Lee, S., Myoung, J., Hwang, S. J., Lim, J. M., Jeong, E. T., Park, S. G., & Youn, S. H. (2021). Effect of the skincare product on facial skin microbial structure and biophysical parameters: A pilot study. MicrobiologyOpen, 10(5), e1236. https://doi.org/10.1002/mbo3.1236 Gowda, V., Sarkar, R., Verma, D., & Das, A. (2024). Probiotics in Dermatology: An Evidence-based Approach. Indian dermatology online journal, 15(4), 571–583. https://doi.org/10.4103/idoj.idoj_614_23 Wang, L., Xu, Y. N., Chu, C. C., Jing, Z., Chen, Y., Zhang, J., Pu, M., Mi, T., Du, Y., Liang, Z., Doraiswamy, C., Zeng, T., Wu, J., & Chen, L. (2021). Facial Skin Microbiota-Mediated Host Response to Pollution Stress Revealed by Microbiome Networks of Individual. mSystems, 6(4), e0031921. https://doi.org/10.1128/mSystems.00319-21 Spada, F., Barnes, T. M., & Greive, K. A. (2018). Skin hydration is significantly increased by a cream formulated to mimic the skin's own natural moisturizing systems. Clinical, cosmetic and investigational dermatology, 11, 491–497. https://doi.org/10.2147/CCID.S177697 Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2017). Impact of Omega-3 Fatty Acids on the Gut Microbiota. International journal of molecular sciences, 18(12), 2645. https://doi.org/10.3390/ijms18122645
- Biophysical Assessments | Sequential
Skin hydration, barrier function and other biophysical measures, captured alongside human and microbiome biomarker data under controlled clinical conditions. Biophysical Assessments for A More In-Depth Analysis In recent years, it has become clear that differentiation is key when creating a formulation for a competitive market; however, it can be incredibly straightforward when backed by data and scientific evidence. Not only will you differentiate your brand, but you will also demonstrate your commitment to providing leading-edge and effective solutions for your customers' personal care and skincare needs. Start your biophysical assesment today Hydration Measurement (Corneometry and TEWL) Gain a comprehensive understanding of your product's impact on moisture retention, skin hydration and overall skin barrier function. This data can guide the development of effective moisturising formulations. Up Perception Questionnaire Uncovering how users experience and interact with products. These surveys offer valuable insights into subjective factors like texture, scent, and overall satisfaction ensuring that your scientific data is enriched. Up Elasticity Measurement (Elastometer) Unravel the effect your product has on the skin’s elasticity through the use of elastometers, allowing you to position your product within a firming category with demonstrated benefits for graceful aging. Up High-Resolution Imaging Use before and after images to provide visual evidence of a product’s impact on the skin’s appearance. These tangible comparisons offer brands the ability to objectively assess changes in the skin. Up Dermatologist Assessment Measure and quantify inflammatory disease, atopic dermatitis (through SCORAD), psoriasis (through PASI), comedogenicity, and other hallmarks of skin conditions, by our board-certified and in-house dermatologists. Up Skin pH Measurement Maintain the delicate balance of the skin's acid mantle with your product by measuring pH to ensure compatibility and minimise the risk of irritation for a gentle, biome-supporting formulation. Up The only way to understand how a product performs is by putting it to the test. Start your biophysical assesment today
- Microbiome Biomarker Analysis | Sequential
Understand how your product changes microbial communities. Composition, diversity and target microorganisms profiled by sequencing and quantitative methods. Microbiome Biomarker Analyses We provide end-to-end clinical microbiome research and testing platform. Supported by a rapidly expanding, industry-leading database of over 50,000+ human samples, our comprehensive services span biophysical product assessments, full study recruitment, and collaborative publishing to drive science-backed solutions. Start Your Study Today Our Layers of Analysis Smart Probes™ (qPCR) Investigate the absolute quantification of key microbes in any sample down to sub-species. Assess how a product impacts the most significant bacteria in a sample. Bacteria Profiling (16s) Investigate all present bacteria in any given sample. Understand how a product impacts the skin's bacterial community. Microbial Gene Expression Uncover how genes are activated in response to lifestyle, environment, & treatments. The effect of product on skin-related microbial gene expression. Fungal Profiling (ITS) Investigate all present fungi in any given sample. Understand how a product impacts the skin's fungal community. Whole Microbial Profiling Investigate all present fungi in any given sample. Understand how a product impacts the skin's bacteria, fungal and viral communities Our Test Areas Skin Test skin formulations, actives and finished products from cleansers, serums and moisturisers to SPFs and treatments. Sequential Smart Probes™ Click on a targeted panel to discover more. Why Sequential? Claim Ready Science Molecular evidence for claims broken down into market positioning insights. Real World Testing Studies done on real people from our global, expansive database. End-to-End Platform We’ll handle everything for you from study design and recruitment to market advice. Flexible & Scalable In-lab or remote studies made possible via our proprietary Sequential Skin Patch™.
- Thank You | Sequential
Thank you for getting in touch! We will review your query and get back to you within 1-2 business days.
- Rosacea Targeted Panel | Sequential
Rosacea is a chronic skin condition affecting an estimated 16 million Americans and millions more worldwide, primarily adults over 30 (National Rosacea Society). TARGETED SKIN PANEL Rosacea Targeted Panel 23 Smart Probes ™ Rosacea Panel Validated targets: Demodex mites, Bacillus oleronius, Corynebacterium kroppenstedtii Absolute Quantification End-to-end Service Qet a Quote Unlock the Secrets of Rosacea with Sequential's Cutting-Edge Microbiome Testing Why Microbiome Testing for Rosacea? Rosacea is a chronic skin condition affecting an estimated 16 million Americans and millions more worldwide, primarily adults over 30 (National Rosacea Society). Characterized by redness, visible blood vessels, and inflammation, rosacea can significantly impact an individual’s quality of life. Research suggests that the skin microbiome plays a crucial role in the development and severity of rosacea. Specifically, imbalances in microbial populations, such as an overgrowth of Demodex mites or harmful bacteria, can exacerbate symptoms. In vivo testing of skincare products for rosacea is essential to ensure that formulations are compatible with the unique microbiome of rosacea-prone skin. Such testing allows researchers to observe real-world effects on microbial balance and inflammation, ensuring that products do not unintentionally worsen symptoms. Without this careful testing, products may disrupt the microbiome further, leading to increased redness, irritation, or flare-ups. Sequential is leading the way in microbiome testing for the industry. With a specialized focus on skin conditions, we have developed an innovative solution tailored to help you understand the root causes of rosacea at the microbial level. Our proprietary sequencing panel is designed specifically to offer in-depth analysis of rosacea-associated microbiota, giving you the tools to transform skincare solutions. Customized Analysis Tailored insights specific to rosacea-prone skin, allowing your R&D team to develop more personalized and effective products. Actionable Data Leverage detailed reports to guide formulation decisions and validate product efficacy with precision. Product Innovation New rosacea treatments or enhancing existing lines, our data helps you create targeted solutions with proven results. Precision Sequencing Target specific microbial communities associated with rosacea development and severity. Smart Probe s ™ Our dedicated team of scientists has developed a revolutionary method for evaluating microbes through our Smart Probes™, a proprietary panel that includes 23 key microbes specifically identified as having the most significant impact on skin health. To further understand the complex relationship between rosacea and the skin microbiome, we utilize qPCR technology. This advanced method allows us to accurately quantify microbial populations on the skin, offering deeper insights into how rosacea affects the balance of beneficial and harmful microbes. By closely monitoring how skincare products interact with these microbes, companies can develop solutions that not only target rosacea symptoms but also help restore a healthier, balanced skin microbiome, providing long-term relief for sufferers. Rosacea Panel Targets Demodex mites (Demodex folliculorum and Demodex brevis) These tiny mites are normally present on the skin but are often found in higher numbers on the skin of individuals with rosacea. Their presence is thought to trigger inflammatory responses. Forton FMN. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea? Dermatol Ther (Heidelb). 2020 Dec;10(6):1229-1253. doi: 10.1007/s13555-020-00458-9. Epub 2020 Oct 23. PMID: 33095403; PMCID: PMC7649190. Kim HS. Microbiota in Rosacea. Am J Clin Dermatol. 2020 Sep;21(Suppl 1):25-35. doi: 10.1007/s40257-020-00546-8. PMID: 32914214; PMCID: PMC7584533. Bacillus oleronius This bacterium has been linked to rosacea, particularly in relation to the inflammatory response associated with the condition. It is often found in higher quantities on the skin of rosacea patients. Corynebacterium kroppenstedtii This bacterium appears to be significantly overrepresented in papulopustular and mixed rosacea compared to healthy skin, with its presence correlating with disease severity and lesion spread, suggesting a potential opportunistic or contributory role in rosacea pathophysiology. Chien AL, Kang S, et al. Characterization and Analysis of the Skin Microbiota in Rosacea. J Am Acad Dermatol. 2020; PMID: 31502207. Industry Leader in Absolute Quantification Sequential’s Smart Probe ™ qPCR approach to microbiome analysis can resolve species and subspecies, giving statistically significant findings between skin conditions on in vivo human samples, compared to conventional sequencing approaches. Relevant Research How Does the Skin Microbiome Influence Rosacea? Unveiling the Microbial Puzzle Read More Articles

